AIM To report the results of the International Nosocomial Infection Control Consortium(INICC)study conducted in Quito,Ecuador.METHODS A device-associated healthcare-acquired infection(DAHAI)prospective surveillance st...AIM To report the results of the International Nosocomial Infection Control Consortium(INICC)study conducted in Quito,Ecuador.METHODS A device-associated healthcare-acquired infection(DAHAI)prospective surveillance study conducted from October 2013 to January 2015 in 2 adult intensive care units(ICUs)from 2 hospitals using the United States Centers for Disease Control/National Healthcare Safety Network(CDC/NHSN)definitions and INICC methods.RESULTS We followed 776 ICU patients for 4818 bed-days.The central line-associated bloodstream infection(CLABSI)rate was 6.5 per 1000 central line(CL)-days,the ventilator-associated pneumonia(VAP)rate was 44.3 per 1000 mechanical ventilator(MV)-days,and the catheterassociated urinary tract infection(CAUTI)rate was 5.7 per 1000 urinary catheter(UC)-days.CLABSI and CAUTI rates in our ICUs were similar to INICC rates[4.9(CLABSI)and 5.3(CAUTI)]and higher than NHSN rates[0.8(CLABSI)and 1.3(CAUTI)]-although device use ratios for CL and UC were higher than INICC and CDC/NSHN's ratios.By contrast,despite the VAP rate was higher than INICC(16.5)and NHSN's rates(1.1),MV DUR was lower in our ICUs.Resistance of A.baumannii to imipenem and meropenem was 75.0%,and of Pseudomonas aeruginosa to ciprofloxacin and piperacillin-tazobactam was higher than 72.7%,all them higher than CDC/NHSN rates.Excess length of stay was 7.4 d for patients with CLABSI,4.8 for patients with VAP and 9.2 for patients CAUTI.Excess crude mortality in ICUs was 30.9%for CLABSI,14.5%for VAP and 17.6%for CAUTI.CONCLUSION DA-HAI rates in our ICUs from Ecuador are higher than United States CDC/NSHN rates and similar to INICC international rates.展开更多
文摘AIM To report the results of the International Nosocomial Infection Control Consortium(INICC)study conducted in Quito,Ecuador.METHODS A device-associated healthcare-acquired infection(DAHAI)prospective surveillance study conducted from October 2013 to January 2015 in 2 adult intensive care units(ICUs)from 2 hospitals using the United States Centers for Disease Control/National Healthcare Safety Network(CDC/NHSN)definitions and INICC methods.RESULTS We followed 776 ICU patients for 4818 bed-days.The central line-associated bloodstream infection(CLABSI)rate was 6.5 per 1000 central line(CL)-days,the ventilator-associated pneumonia(VAP)rate was 44.3 per 1000 mechanical ventilator(MV)-days,and the catheterassociated urinary tract infection(CAUTI)rate was 5.7 per 1000 urinary catheter(UC)-days.CLABSI and CAUTI rates in our ICUs were similar to INICC rates[4.9(CLABSI)and 5.3(CAUTI)]and higher than NHSN rates[0.8(CLABSI)and 1.3(CAUTI)]-although device use ratios for CL and UC were higher than INICC and CDC/NSHN's ratios.By contrast,despite the VAP rate was higher than INICC(16.5)and NHSN's rates(1.1),MV DUR was lower in our ICUs.Resistance of A.baumannii to imipenem and meropenem was 75.0%,and of Pseudomonas aeruginosa to ciprofloxacin and piperacillin-tazobactam was higher than 72.7%,all them higher than CDC/NHSN rates.Excess length of stay was 7.4 d for patients with CLABSI,4.8 for patients with VAP and 9.2 for patients CAUTI.Excess crude mortality in ICUs was 30.9%for CLABSI,14.5%for VAP and 17.6%for CAUTI.CONCLUSION DA-HAI rates in our ICUs from Ecuador are higher than United States CDC/NSHN rates and similar to INICC international rates.
